Follow
Casey Theriot
Title
Cited by
Cited by
Year
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
C Ma, M Han, B Heinrich, Q Fu, Q Zhang, M Sandhu, D Agdashian, ...
Science 360 (6391), eaan5931, 2018
8802018
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
CM Theriot, MJ Koenigsknecht, PE Carlson Jr, GE Hatton, AM Nelson, ...
Nature communications 5 (1), 3114, 2014
8792014
Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine
CM Theriot, AA Bowman, VB Young
MSphere 1 (1), e00045-15, 2016
3342016
High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution
BJ Callahan, J Wong, C Heiner, S Oh, CM Theriot, AS Gulati, SK McGill, ...
Nucleic acids research 47 (18), e103-e103, 2019
2932019
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
CM Theriot, VB Young
Annual review of microbiology 69, 445-461, 2015
2862015
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection
AE Reeves, CM Theriot, IL Bergin, GB Huffnagle, PD Schloss, VB Young
Gut microbes 2 (3), 145-158, 2011
2772011
Diversification of host bile acids by members of the gut microbiota
JA Winston, CM Theriot
Gut microbes 11 (2), 158-171, 2020
2332020
Hydrolysis of organophosphorus compounds by microbial enzymes
CM Theriot, AM Grunden
Applied Microbiology and Biotechnology 89, 35-43, 2011
1812011
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains
CM Theriot, CC Koumpouras, PE Carlson, II Bergin, DM Aronoff, ...
Gut microbes 2 (6), 326-334, 2011
1702011
Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids
R Thanissery, JA Winston, CM Theriot
Anaerobe 45, 86-100, 2017
1672017
Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract
MJ Koenigsknecht, CM Theriot, IL Bergin, CA Schumacher, PD Schloss, ...
Infection and immunity 83 (3), 934-941, 2015
1512015
Metabolic model-based integration of microbiome taxonomic and metabolomic profiles elucidates mechanistic links between ecological and metabolic variation
C Noecker, A Eng, S Srinivasan, CM Theriot, VB Young, JK Jansson, ...
MSystems 1 (1), e00013-15, 2016
1492016
Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract
MH Foley, S O’Flaherty, R Barrangou, CM Theriot
PLoS pathogens 15 (3), e1007581, 2019
1482019
Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
AM Seekatz, CM Theriot, K Rao, YM Chang, AE Freeman, JY Kao, ...
Anaerobe 53, 64-73, 2018
1402018
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract
JA Winston, CM Theriot
Anaerobe 41, 44-50, 2016
1222016
Fecal microbiota transplantation eliminates Clostridium difficile in a murine model of relapsing disease
AM Seekatz, CM Theriot, CT Molloy, KL Wozniak, IL Bergin, VB Young
Infection and immunity 83 (10), 3838-3846, 2015
1222015
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ...
MBio 11 (2), e00019-20, 2020
1002020
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection
CM Theriot, VB Young
Gut microbes 5 (1), 86-95, 2014
912014
Shifts in the gut metabolome and Clostridium difficile transcriptome throughout colonization and infection in a mouse model
JR Fletcher, S Erwin, C Lanzas, CM Theriot
Msphere 3 (2), e00089-18, 2018
832018
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection
CM Bassis, CM Theriot, VB Young
Antimicrobial agents and chemotherapy 58 (5), 2767-2774, 2014
752014
The system can't perform the operation now. Try again later.
Articles 1–20